Feature Article
Atypical Lipomatous Tumors/Well-differentiated Liposarcomas: Clinical Outcome of 67 Patients
Abstract
Atypical lipomatous tumors/well-differentiated liposarcomas are low-grade malignant mesenchymal neoplasms with high propensity to local recurrence and potential to dedifferentiate to higher grades over time. However, the published risks of local recurrence and dedifferentiation vary, and no unified treatment and follow-up plan has been accepted. We performed a study to evaluate the long-term clinical behavior and proper treatment and follow-up strategy for these tumors. We retrospectively reviewed the files of 101 patients treated between 1990 and 2008 with the diagnosis of atypical lipomatous tumors/well-differentiated liposarcomas. For 67 of these patients, complete data and 2-year minimum follow-up were available and were included in the study; 47 patients (group A) had primary surgical treatment at our institution and 20 patients (group B) were referred after ≥1 local recurrences. Mean follow-up was 81 months (range, 24–229 months). The local recurrence rate of primary atypical lipomatous tumors/well-differentiated liposarcomas was 10.6% (5/47 group A patients). The local re-recurrence rate of the recurrent atypical lipomatous tumors/well-differentiated liposarcomas was 52% (13/67 group A and B patients). Recurrences developed as late as 140 months after diagnosis and treatment. The rate of dedifferentiation at recurrences was 4% (1/25 group A and B patients with recurrent tumors). No patients developed metastases. Atypical lipomatous tumors/well-differentiated liposarcomas are associated with an increased rate of local re-recurrence and low risk of dedifferentiation at recurrences. Long-term follow-up is recommended for early diagnosis and treatment of local recurrences.
- 1.Laurino L, Furlanetto A, Orvieto E, Dei Tos AP. Well-differentiated liposarcoma (atypical lipomatous tumors). Semin Diagn Pathol. 2001; 18(4):258–262. Medline, Google Scholar
- 2.Billing V, Mertens F, Domanski HA, Rydholm A. Deep-seated ordinary and atypical lipomas: histopathology, cytogenetics, clinical features, and outcome in 215 tumours of the extremity and trunk wall. J Bone Joint Surg Br. 2008; 90(7):929–933.
10.1302/0301-620X.90B7.20348 Crossref Medline, Google Scholar - 3.Dei Tos AP, Pedeutour F. Atypical lipomatous tumour /well differentiated liposarcoma. In: , eds. World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of Soft Tissue and Bone. Lyon, France: IARC Press; 2002:35–37. Google Scholar
- 4.Evans HL, Soule EH, Winkelmann RK. Atypical lipoma, atypical intramuscular lipoma, and well differentiated retroperitoneal liposarcoma: a reappraisal of 30 cases formerly classified as well differentiated liposarcoma. Cancer. 1979; 43(2):574–584.
10.1002/1097-0142(197902)43:2<574::AID-CNCR2820430226>3.0.CO;2-7 Crossref Medline, Google Scholar - 5.Azumi N, Curtis J, Kempson RL, Hendrickson MR. Atypical and malignant neoplasms showing lipomatous differentiation. A study of 111 cases. Am J Surg Pathol. 1987; 11(3):161–183.
10.1097/00000478-198703000-00001 Crossref Medline, Google Scholar - 6.Dei Tos AP. Liposarcoma: new entities and evolving concepts. Ann Diagn Pathol. 2000; 4(4):252–266.
10.1053/adpa.2000.8133 Crossref Medline, Google Scholar - 7.Weiss SW, Rao VK. Well-differentiated liposarcoma (atypical lipoma) of deep soft tissue of the extremities, retroperitoneum, and miscellaneous sites. A follow-up study of 92 cases with analysis of the incidence of “dedifferentiation.”Am J Surg Pathol. 1992; 16(11):1051–1058.
10.1097/00000478-199211000-00003 Crossref Medline, Google Scholar - 8.Evans HL. Atypical lipomatous tumor, its variants, and its combined forms: a study of 61 cases, with a minimum follow-up of 10 years. Am J Surg Pathol. 2007; 31(1):1–14.
10.1097/01.pas.0000213406.95440.7a Crossref Medline, Google Scholar - 9.Pilotti S, Della Torre G, Lavarino C, Distinct mdm2/p53 expression patterns in liposarcoma subgroups: implications for different pathogenetic mechanisms. J Pathol. 1997; 181(1):14–24.
10.1002/(SICI)1096-9896(199701)181:1<14::AID-PATH730>3.0.CO;2-O Crossref Medline, Google Scholar - 10.Binh MB, Sastre-Garau X, Guillou L, MDM2 and CDK4 immunostainings are useful adjuncts in diagnosing well-differentiated and dedifferentiated liposarcoma subtypes: a comparative analysis of 559 soft tissue neoplasms with genetic data. Am J Surg Pathol. 2005; 29(10):1340–1347.
10.1097/01.pas.0000170343.09562.39 Crossref Medline, Google Scholar - 11.Shimada S, Ishizawa T, Ishizawa K, Matsumura T, Hasegawa T, Hirose T. The value of MDM2 and CDK4 amplification levels using real-time polymerase chain reaction for the differential diagnosis of liposarcomas and their histologic mimickers [published online ahead of print July 7, 2006]. Hum Pathol. 2006; 37(9):1123–1129.
10.1016/j.humpath.2006.04.010 Crossref Medline, Google Scholar - 12.Weaver J, Downs-Kelly E, Goldblum JR, Fluorescence in situ hybridization for MDM2 gene amplification as a diagnostic tool in lipomatous neoplasms [published online ahead of print May 23, 2008]. Mod Pathol. 2008; 21(8):943–949.
10.1038/modpathol.2008.84 Crossref Medline, Google Scholar - 13.Weaver J, Rao P, Goldblum JR, Can MDM2 analytical tests performed on core needle biopsy be relied upon to diagnose well-differentiated liposarcoma [published online ahead of print May 21, 2010]?Mod Pathol. 2010; 23(10):1301–1306.
10.1038/modpathol.2010.106 Crossref Medline, Google Scholar - 14.Knight JC, Renwick PJ, Dal Cin P, Van den Berghe H, Fletcher CD. Translocation t(12;16)(q13;p11) in myxoid liposarcoma and round cell liposarcoma: molecular and cytogenetic analysis. Cancer Res. 1995; 55(1):24–27. Medline, Google Scholar
- 15.Hameed M. Pathology and genetics of adipocytic tumors. Cytogenet Genome Res. 2007; 118(2–4):138–147.
10.1159/000108294 Crossref Medline, Google Scholar - 16.Hostein I, Pelmus M, Aurias A, Pedeutour F, Mathoulin-Pélissier S, Coindre JM. Evaluation of MDM2 and CDK4 amplification by real-time PCR on paraffin wax-embedded material: a potential tool for the diagnosis of atypical lipomatous tumours/well-differentiated liposarcomas. J Pathol. 2004; 202(1):95–102.
10.1002/path.1495 Crossref Medline, Google Scholar - 17.Italiano A, Bianchini L, Keslair F, HMGA2 is the partner of MDM2 in well-differentiated and dedifferentiated liposarcomas whereas CDK4 belongs to a distinct inconsistent amplicon. Int J Cancer. 2008; 122(10):2233–2241.
10.1002/ijc.23380 Crossref Medline, Google Scholar - 18.Italiano A, Bianchini L, Gjernes E, Clinical and biological significance of CDK4 amplification in well-differentiated and de-differentiated liposarcomas [published online ahead of print September 8, 2009]. Clin Cancer Res. 2009; 15(18):5696–5703.
10.1158/1078-0432.CCR-08-3185 Crossref Medline, Google Scholar - 19.Zagars GK, Goswitz MS, Pollack A. Liposarcoma: outcome and prognostic factors following conservation surgery and radiation therapy. Int J Radiat Oncol Biol Phys. 1996; 36(2):311–319.
10.1016/S0360-3016(96)00265-9 Crossref Medline, Google Scholar - 20.Sommerville SM, Patton JT, Luscombe JC, Mangham DC, Grimer RJ. Clinical outcomes of deep atypical lipomas (well-differentiated lipoma-like liposarcomas) of the extremities. ANZ J Surg. 2005; 75(9):803–806.
10.1111/j.1445-2197.2005.03519.x Crossref Medline, Google Scholar - 21.Lucas DR, Nascimento AG, Sanjay BK, Rock MG. Well-differentiated liposarcoma. The Mayo Clinic experience with 58 cases. Am J Clin Pathol. 1994; 102(5):677–683. Crossref Medline, Google Scholar
- 22.Rozental TD, Khoury LD, Donthineni-Rao R, Lackman RD. Atypical lipomatous masses of the extremities: outcome of surgical treatment. Clin Orthop Relat Res. 2002; (398):203–211.
10.1097/00003086-200205000-00029 Crossref Medline, Google Scholar - 23.Bassett MD, Schuetze SM, Disteche C, Deep-seated, well differentiated lipomatous tumors of the chest wall and extremities: the role of cytogenetics in classification and prognostication. Cancer. 2005; 103(2):409–416.
10.1002/cncr.20779 Crossref Medline, Google Scholar - 24.Serpell JW, Chen RY. Review of large deep lipomatous tumours. ANZ J Surg. 2007; 77(7):524–529.
10.1111/j.1445-2197.2007.04042.x Crossref Medline, Google Scholar - 25.Orndal C, Mandahl N, Rydholm A, Chromosomal evolution and tumor progression in a myxoid liposarcoma. Acta Orthop Scand. 1990; 61(2):99–105.
10.3109/17453679009006497 Crossref Medline, Google Scholar - 26.Kuhnen C, Mentzel T, Lehnhardt M, Homann HH, Sciot R, Debiec-Rychter M. Lipoma and atypical lipomatous tumor within the same neoplasia: evidence for a continuous transition [in German]. Pathologe. 2010; 31(2):129–134.
10.1007/s00292-009-1257-6 Crossref Medline, Google Scholar - 27.Storlazzi CT, Mertens F, Domanski H, Fletcher CD, Wiegant J, Mandahl N. Ring chromosomes and low-grade gene amplification in an atypical lipomatous tumor with minimal nuclear atypia. Int J Oncol. 2003; 23(1):67–71. Medline, Google Scholar
- 28.Micci F, Bjerkehagen B, Heim S. Pairwise comparison of genomic imbalances between primary and recurrent well differentiated liposarcomas. Cancer Genet Cytogenet. 2007; 178(2):163–167.
10.1016/j.cancergencyto.2007.06.019 Crossref Medline, Google Scholar - 29.Kooby DA, Antonescu CR, Brennan MF, Singer S. Atypical lipomatous tumor/well-differentiated liposarcoma of the extremity and trunk wall: importance of histological subtype with treatment recommendations. Ann Surg Oncol. 2004; 11(1):78–84.
10.1007/BF02524350 Crossref Medline, Google Scholar
